Hospital Consolidation And Digital Analytics Will Redefine Healthcare

Published
11 Sep 24
Updated
21 Aug 25
AnalystConsensusTarget's Fair Value
US$24.83
2.9% overvalued intrinsic discount
21 Aug
US$25.55
Loading
1Y
27.1%
7D
4.2%

Author's Valuation

US$24.8

2.9% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on21 Aug 25
Fair value Increased 9.56%

Analysts have raised Premier’s price target to $24.83, citing strong Q4 results and improved fiscal 2026 estimates driven by higher demand for advisory and performance services, though ongoing net administrative fee pressure tempers further upside. Analyst Commentary Bullish analysts are raising price targets due to better-than-expected Q4 results and an in-line fiscal 2026 outlook.

Shared on30 Apr 25
Fair value Increased 6.02%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 4.27%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 14%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 11%

AnalystConsensusTarget has increased profit margin from 7.4% to 9.9% and decreased future PE multiple from 22.8x to 17.3x.